Fundraising Fox

Johannes Fruehauf

Investor

General Partner at Mission Biocapital

Cambridge, Massachusetts

Writes $500K checks · typically $1.5M

FoundedQuralis

About

Johannes Fruehauf is a physician‑scientist with clinical experience in Europe and Africa, giving him a global healthcare perspective, and a serial biotech founder who built the LabCentral/BioLabs network supporting early-stage biotech.

Invests in

AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials

Experience

  1. LabCentralFounder and Chairmancurrent2025 — presentKendall Square, Cambridge
  2. LabCentralFounder and President/CEO2012 — 2025
  3. Mission BioCapitalGeneral Partner, Co-Foundercurrent2011 — presentGreater Boston Area
  4. BioLabsPresident & CEO, Foundercurrent2009 — present
  5. Zag BioInvestor and Board Membercurrent2023 — present
  6. Volnay TherapeuticsFounder, President, Member of the Boardcurrent2022 — presentBoston and Europe
  7. QurAlisBoard Membercurrent2018 — presentCambridge, MA
  8. Vaxess TechnologiesBoard Member2016 — 2025
  9. Arkuda TherapeuticsInvestor and Board Member2019 — 2025Watertown, Massachusetts, United States
  10. Tidal TherapeuticsFounding Investor and Board Director2018 — 2021Cambridge, MA
  11. TotientFounding Investor and Observer2018 — 2021Cambridge, Massachusetts, United States
  12. Sentien Biotechnologies, Inc.Board Director2016 — 2021Cambridge, MA
  13. Pandion TherapeuticsInvestor and Board Observer2018 — 2020Cambridge MA
  14. Mitokinin IncBoard Director2017 — 2018NYC/SF
  15. ViThera PharmaceuticalsFounder, Chairman2011 — 2015Cambridge, MA
  16. Aura BiosciencesVice President, Research and Development2009 — 2011
  17. Cequent Pharmaceuticals (now Marina Biotech NASDAQ: MRNA)Vice President, Medical Affairs (Consultant)2009 — 2010
  18. Cequent Pharmaceuticals (now Marina Biotech NASDAQ: MRNA)Vice President, Research2006 — 2010Cambridge, MA
  19. Cequent Pharmaceuticals (now Marina Biotech NASDAQ: MRNA)Director, Preclinical and Clinical Development2006 — 2007
  20. BIDMC/Harvard Medical SchoolSenior Research Fellow2004 — 2007

Education

  1. Harvard Medical SchoolPostdoc, Molecular Biology2002 — 2004
  2. SLP Boston 2012Fellow, Entrepreneurship/Entrepreneurial Studies2011 — 2012
  3. Goethe University FrankfurtMD, Medicine1989 — 1997
  4. University of MontpellierMedicine1994 — 1995
  5. Franziskaner Gymnasium Kreuzburg

Skills & more

Drug Discovery62Biotechnology95Lifesciences46Clinical Development18Cancer8Clinical Trials13Technology Transfer42In Vivo10Assay Development14Drug Delivery6Start-ups37Entrepreneurship21
+12 moreMolecular BiologyVenture CapitalHealthcareDrug DevelopmentBiochemistryCommercializationPharmaceuticsBiopharmaceuticalsPharmaceutical IndustryINDStrategyCell Biology

Languages English · French · German

From Johannes's professional profile.

Same school

Shared employers

Deals · 1

Vaxess Technologies, Inc.Board seat

via Mission Biocapital · filed Mar 2021 · $2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Mission Biocapital

Network3

Investors connected to Johannes in public investor directories — a warm-intro map.